Barclays Initiates Coverage on Anteris Technologies Global (NASDAQ:AVR)

Equities researchers at Barclays assumed coverage on shares of Anteris Technologies Global (NASDAQ:AVRGet Free Report) in a note issued to investors on Tuesday, Marketbeat reports. The brokerage set an “overweight” rating and a $22.00 price target on the stock. Barclays‘s price objective would suggest a potential upside of 290.76% from the company’s current price.

Anteris Technologies Global Price Performance

Shares of NASDAQ AVR opened at $5.63 on Tuesday. Anteris Technologies Global has a 12 month low of $5.10 and a 12 month high of $6.00.

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Recommended Stories

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.